These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11759229)

  • 1. [Rheumatoid arthritis: determination of the current status].
    Michel BA
    Z Rheumatol; 2001 Oct; 60(5):307-8. PubMed ID: 11759229
    [No Abstract]   [Full Text] [Related]  

  • 2. The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis.
    Kavanaugh A; Cohen S; Cush JJ
    J Rheumatol; 2004 Oct; 31(10):1881-4. PubMed ID: 15468347
    [No Abstract]   [Full Text] [Related]  

  • 3. Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade.
    Redlich K; Schett G; Steiner G; Hayer S; Wagner EF; Smolen JS
    Arthritis Rheum; 2003 Dec; 48(12):3308-19. PubMed ID: 14673982
    [No Abstract]   [Full Text] [Related]  

  • 4. [TNF-alpha blocker in rheumatoid arthritis. Who should be treated with the new substances?].
    MMW Fortschr Med; 2000 Nov; 142(44):6. PubMed ID: 11107796
    [No Abstract]   [Full Text] [Related]  

  • 5. TNF alpha blockade in rheumatoid arthritis--time for caution or enthusiasm?
    Hamilton JD; Wilson HE; Madhok R; McInnes IB; Capell HA
    Scott Med J; 2001 Jun; 46(3):67-70. PubMed ID: 11501322
    [No Abstract]   [Full Text] [Related]  

  • 6. Access to disease modifying treatments for rheumatoid arthritis patients.
    Furst DE; Breedveld FC; Burmester GR; Crofford L; Emery P; Feldman M; Kalden JR; Kavanaugh A; Keystone E; Lipsky PE; Maini RN; Moreland L; Smolen JS; Van De Putte L; Vischer T; Weinblatt M; Weissman M
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I129-30. PubMed ID: 10577989
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a pharmacoeconomic argument supporting the use of tumor necrosis factor inhibitors in early rheumatoid arthritis?
    Kavanaugh A
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):346-7. PubMed ID: 16932716
    [No Abstract]   [Full Text] [Related]  

  • 8. [TNF-alpha antagonists in therapy of rheumatoid arthritis].
    Gross WL; Gause A
    Z Rheumatol; 2003 Jun; 62(3):217. PubMed ID: 12931691
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Verhoeven AC; Boers M
    Ned Tijdschr Geneeskd; 2001 Nov; 145(47):2294-5. PubMed ID: 11760611
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of biologic agents in rheumatoid arthritis: introduction.
    Silman AJ
    Rheumatology (Oxford); 2011 Sep; 50 Suppl 4():iv3-4. PubMed ID: 21859703
    [No Abstract]   [Full Text] [Related]  

  • 11. Tailored approach to rheumatoid arthritis treatment with TNF inhibitors: where do we stand?
    Caporali R; Codullo V; Cipriani P; Giacomelli R
    Rheumatology (Oxford); 2018 Oct; 57(57 Suppl 7):vii1-vii4. PubMed ID: 30289536
    [No Abstract]   [Full Text] [Related]  

  • 12. The updated guidelines on the use of rituximab in rheumatoid arthritis.
    Lopez-Olivo MA; Tayar JH; Suarez-Almazor ME
    Rheumatology (Oxford); 2011 Dec; 50(12):2153-4. PubMed ID: 21546350
    [No Abstract]   [Full Text] [Related]  

  • 13. New drugs for rheumatoid arthritis.
    Roberts LJ
    N Engl J Med; 2004 Dec; 351(25):2659-61; author reply 2659-61. PubMed ID: 15602032
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug treatments for rheumatoid arthritis: looking backwards to move forwards.
    Miossec P
    BMJ; 2015 Mar; 350():h1192. PubMed ID: 25769296
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness and safety of the treatment with tumour necrosis factor alpha antagonists in rheumatoid arthritis patients].
    Arenere Mendoza M; Navarro Aznárez H; Rabanaque Hernández MJ; Manero Ruiz FJ
    Med Clin (Barc); 2005 Jun; 125(1):35-6. PubMed ID: 15960943
    [No Abstract]   [Full Text] [Related]  

  • 16. Rheumatoid arthritis.
    Burchini G; Orsi C
    N Engl J Med; 2004 Sep; 351(13):1360-1; author reply 1360-1. PubMed ID: 15385669
    [No Abstract]   [Full Text] [Related]  

  • 17. Escalated conventional therapy for rheumatoid arthritis patients.
    Smith MD
    Rheumatology (Oxford); 2004 Sep; 43(9):1199; author reply 1199-1200. PubMed ID: 15317963
    [No Abstract]   [Full Text] [Related]  

  • 18. Drivers of costly treatment strategies in rheumatoid arthritis.
    Huizinga TW; Gröndal G
    Lancet; 2016 Jul; 388(10041):213-4. PubMed ID: 27197691
    [No Abstract]   [Full Text] [Related]  

  • 19. Adalimumab for rheumatoid arthritis?
    Ebell M; Kripke C
    Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of tumor necrosis factor-alpha inhibitors on lung lesions with rheumatoid arthritis.
    Inoue K; Takano H; Yanagisawa R; Yoshikawa T
    Chest; 2003 Jul; 124(1):413-4; author reply 414. PubMed ID: 12853558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.